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Medical message boards are online resources where users with a particular condition exchange informa-
tion, some of which they might not otherwise share with medical providers. Many of these boards con-
tain a large number of posts and contain patient opinions and experiences that would be potentially
useful to clinicians and researchers. We present an approach that is able to collect a corpus of medical
message board posts, de-identify the corpus, and extract information on potential adverse drug effects
discussed by users. Using a corpus of posts to breast cancer message boards, we identiﬁed drug event
pairs using co-occurrence statistics. We then compared the identiﬁed drug event pairs with adverse
effects listed on the package labels of tamoxifen, anastrozole, exemestane, and letrozole. Of the pairs
identiﬁed by our system, 75–80% were documented on the drug labels. Some of the undocumented pairs
may represent previously unidentiﬁed adverse drug effects.
 2011 Elsevier Inc. All rights reserved.1. Introduction
Internet message boards provide a rich data resource for a vari-
ety of purposes. Many boards contain a large number of candid
messages which can be used to learn more about a given popula-
tion without relying on costly methods of data collection, such as
focus groups. For example, this medium has been intensively ex-
plored by marketing researchers. Glance et al. [1] have developed
a comprehensive system that crawls message boards and derives
several metrics about consumer products that characterize how
users rate those products and how frequently people discuss them.
Feldman et al. [2] have also published a system that extracts com-
parisons between different products and the attributes that they
are compared on. Other systems have focused on different forms
of web content such as product reviews in order to extract people’s
sentiment about certain products [3,4] or have relied on the pages
produced by Google searches to extract the reputation of a product
[5].
Even though it is well known that the lay public frequently uses
online resources such as message boards to seek and exchange
medical information [9–13], medical message boards have beenll rights reserved.
sylvania, School of Medicine,
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Benton).examined to a much lesser degree. Malouf et al. [14] applied sen-
timent analysis to epilepsy blogs in order to extract patient prefer-
ences for different seizure disorder drugs. Pharmacovigilance
researchers have also applied data mining methods in order to ex-
tract signals of possible adverse drug events from databases such
as the Adverse Event Reporting System (AERS) [15–17]. Electronic
health records have also been examined to identify similar signals
[18] as well as to generate biomedical hypotheses [19]. Though
there is a history of data mining in the medical domain, it has
yet to exploit the knowledge that can be derived from online
user-generated content.
The burgeoning of medical message boards provides evidence of
the increasing frequency of discussions about health-related mat-
ters in society at large, and the boards in turn provide a fertile
source of data for identifying and evaluating the advice, concerns
and opinions that are sought and provided by message board users.
Users of medical message boards often ask questions and seek ad-
vice about topics that they may be hesitant to discuss with their
health care providers. One such topic is concern about adverse ef-
fects experienced with some medications, especially those pre-
scribed for serious conditions such as cancer, where patient
anxiety may be heightened by the characteristics of the disease
and the long-term exposure to potentially toxic drugs.
Although adverse events should be reported through available
channels, such as the AERS of the US Food and Drug Administra-
tion, many patients do not do so, perhaps because of ignorance
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vider attitude, their extreme illness, etc. Instead, they often use
informal networks such as internet message boards to report and
discuss adverse events. However, these data remain largely un-
tapped by researchers in medical and healthcare domains.
To date, there are no reports in the medical or social sciences lit-
erature that apply methods to extract information from the text of
medical discussion board content to identify and analyze reports of
adverse drug events. While there are several studies evaluating
discussions in message boards and chat rooms, these have used
qualitative research methods [20–24]. Reasons for this include
the unstructured nature of message board text, the use of non-
standard abbreviations, a wide variation in the use of syntax and
spelling, the temporal relationship between posts in a single mes-
sage thread, and references within messages to other threads.
Many systems have focused on extracting information from on-
line resources other than message boards, particularly blogs.
Although blogs are another venue where users may share personal
experiences and opinions, they consist of a single main author
privileged to post new topics. Readers of the blog may or may
not be permitted to comment on the topics that the main author
posts. On the other hand, all message board users are equally priv-
ileged to introduce new topics and reply to posts made by other
users. These blog-focused systems are able to retrieve posts con-
taining opinions about current events [6], identify album and song
titles and users’ sentiment regarding them [7], and cluster blog
posts by content [8]. However, the tasks that these systems were
designed to perform are not focused on extracting medical infor-
mation from these posts, and blogs are structurally different than
message boards, necessitating the use of techniques speciﬁc to
medical message boards.
Effective identiﬁcation of adverse events related to medications
or therapeutics has tremendous public health implications. Using
the growing online media to generate appropriate medical hypoth-
eses presents great potential to help address this issue. We present
here methods that we used to identify such information, speciﬁ-
cally self-reported adverse events that may be associated with four
hormonal medications that are commonly used in the treatment of
breast cancer.2. Methods
In order to address the unique difﬁculties posed by medical
message boards, our system was structured as illustrated in Fig. 1.Sites
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Fig. 1. Overview of the system architecture. (1) Corpus generation; (2) removal of
personal identiﬁers; (3) construction of controlled vocabulary; (4) information
extraction.In step 1, the system downloaded message post pages from a set
of message board sites and removed content unrelated to the posts
from these pages. In step 2, the de-identiﬁcation module removed
personal identiﬁers (e.g., e-mail addresses, phone numbers, and
usernames) from these posts. In step 3 we developed the con-
trolled vocabulary by scraping drug and side effect terms from var-
ious databases and websites using automated scripts in the Scrape
Terms process. Afterwards, terms that were not indicative of a drug
or event/symptom were removed by hand in the curation process.
In step 4, all terms in the controlled vocabulary were identiﬁed in
our de-identiﬁed corpus and any pair of terms that co-occurred at a
statistically signiﬁcant rate was treated as a ‘‘ﬁnding’’.
2.1. Step 1: Corpus development
The breast cancer message board corpus was developed in three
steps: message board identiﬁcation, download, and anonymiza-
tion. A collection of breast cancer message boards was identiﬁed
by manually searching for large message boards speciﬁcally de-
voted to breast cancer. A custom-built web crawler, a program to
browse the Internet and download pages, was used to download
messages from each message board. Since each board was struc-
tured differently, the crawler had to be customized separately for
each site in order to make sure that only message post and index
page links within that board were followed. These saved pages
were ‘‘cleaned’’ by extracting the following ﬁelds from each
message:
 Author (replaced with an anonymous identiﬁer in the anonymi-
zation step).
 Thread ID (the unique identiﬁer for this message’s thread).
 Time posted.
 Message body.
 Message subject.
This cleaning step was necessary since much of the text on a
webpage is unrelated to the users’ posts. Such extraneous text
may include the header, footer, navigation bar, and Javascript for
the page. After preprocessing, only about 48% of the tokens, de-
ﬁned as strings of characters delimited by whitespace, in the origi-
nal HTML pages were kept to generate the corpus. The ﬁnal corpus
contained over 1.1 million messages, comprising over 100 million
words; the average message entry is 99 tokens long, with standard
deviation of 135 tokens. This is because a large proportion of the
messages tend to be very short (1–4 tokens), with a very long tail
of increasingly long messages.
The following sites were used to generate the corpus:
breastcancer.org, komen.org, csn.cancer.org, bcsupport.org, health-
boards.com, cancercompass.com, webmd.com, dailystrength.org,
revolutionhealth.com, ehealthforum.com, oprah.com. Most mes-
sages from the breast cancer corpus are from breastcancer.org
(70%), komen.org (16.5%), and csn.cancer.org (9.2%). Each of the
other sites was responsible for 1% or less of the total entries. This
Zipﬁan distribution of messages over sites, where a select few sites
contain many messages and a long list of sites contain much fewer,
is to be expected.
2.2. Step 2: Anonymization
In order to de-identify the messages, we created an anonymizer
to remove the following information:
 Email addresses.
 Phone numbers.
 Uniform Resource Locators (URLs).
 Social Security Numbers (SSNs).
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 Proper names.
Although the breast cancer message board corpus consisted of
posts that were made publicly available online, in order to protect
the identities of the authors, we removed these possible identiﬁers.
Although our approach relies chieﬂy on co-occurrence statistics,
we also referred back to the original de-identiﬁed messages in or-
der to verify that pairs found to be statistically signiﬁcant were
actually related within the messages. The University of Pennsylva-
nia institutional review board requires that message board posts
be de-identiﬁed before being used for research purposes (either
analyzed qualitatively or extracting co-occurrence statistics).
Email addresses, phone numbers, URLs, and SSNs were easily
removed using regular expressions, a tool used to recognize strings
of characters, since these types of identifying information all have
predictable structures. There seemed to be very few instances of
these. However, usernames and proper names were more difﬁcult
to remove since message posts often contain spelling errors, non-
standard constructions, inconsistent capitalization, and a wide
variety of nicknames and usernames that would not be found in
list of proper names. We ﬁrst used the 2008 Stanford Named Entity
Recognizer (NER) [25] trained on a combination of the Conference
on Natural Language Learning (CoNLL) 03, Message Understanding
Conference (MUC) 6, MUC-7, and Automatic Content Extraction
(ACE) 08 corpora to ﬁnd proper names.
The performance of the Stanford NER was evaluated, using the
precision, recall, and F-score metrics:
Precision ¼ Number of names correctly removed by NER
Total number of tokens removed by NER
ð1Þ
Recall ¼ Number of names correctly removed by NER
Total number of names in the sample
ð2Þ
F-score ¼ 2 ðPrecision  RecallÞðPrecisionþ RecallÞ
 
ð3Þ
Over a random sample of 500 messages containing 523 names
identiﬁed by a human coder, the Stanford NER exhibited mediocre
performance, achieving precision of 69.6%, recall of 77.6%, and an
F-score of 73.4%. This is likely due to the fact that it was not trained
on message board text and relied on features that may be indicative
of proper names in less noisy text, but not in message board text
(e.g., capitalization). In addition, the Stanford NER was not designed
to identify usernames, which could be very different from proper
names. Thus, we had to design and implement our own system to
remove both proper names and usernames [26].
To do so, we trained a conditional random ﬁeld (CRF) [27] over a
1000 message sample from the breast cancer corpus consisting of
91,344 tokens, of which 822 were proper names and 682 were
usernames. Proper names and usernames were manually identiﬁed
and tagged by a human coder in order to form this training set.
Each token was described by a feature vector. Some examples of
features in this vector were whether the token belonged to a par-
ticular dictionary (e.g., proper names, common English words, and
very common English words), whether the token matched a user-
name in this thread, the position of the token in the message, and
the case of the token. The features for the previous and following
two tokens were also included in each token’s feature vector.
To remove proper names and usernames from a particular mes-
sage,we tokenized themessage and ran theCRFover the feature vec-
tors for these tokens. These vectors included features that are useful
to named entity recognition across domains (e.g., is the token title
case, does it belong to a list of names, is it a possible misspelling of
a name) as well as features that take advantage of the structure of
message boards andmessage board posts (e.g., does the token often
occur near the beginning or end of posts, does the token have a high
tf–idf value out of all tokens in a particular message board whentreatingentiremessageboards as documents). Any tokenwith apre-
dicted probability of being a name greater than 0.05 was replaced
with an anonymous tag. This 0.05 threshold was chosen in order to
maximize the recall of the anonymizer without removing too many
non-name tokens. Testing this system over 500 messages, contain-
ing 483 total names, sampled from the breast cancer corpus, yielded
a precision of 67.4%, recall of 98.1%, and F-score of 79.9% for remov-
ing names. Our anonymizer demonstrates precision comparable to
the Stanford NER’s, a much higher recall (98.1% compared to
77.6%), and is designed to remove usernames aswell. A samplemes-
sage from the de-identiﬁed corpus is provided below:Block 1 Sample message after anonymization. The message
was altered to prevent searching on the Internet for its original
posting and subsequent identiﬁcation of the poster.<message> <body>This is a terrriﬁc radio interview with
<name></name> <name></name> whose article I refer-
enced in the topic about cancer not being a disease. I am
convinced with all the research I’ve done about the liver,
and what Dr. <name></name> recommends also, this
could be the answer to the cause of all imbalance. Years
ago, my father was told that the liver was the clue to all
disease by a great Dr. he went to. I am doing this cleanse
next, since I just ﬁnished the colon cleanse. Any thoughts
after listening to this broadcast would be appreciated.
<url_body></url_body> Here are ﬂush recipies: <url_-
body></url_body></body><author>AUTHOR-79_701725-0</author>
<url>http://community.breastcancer.org/forum/</url>
<condition>breast cancer</condition>
<thread_id>79_701725</thread_id>
<time>Mar 7, 2008 11:31 am</time>
<subject>liver and gall bladder ﬂush</subject> </message>2.3. Step 3: Controlled vocabulary
As mentioned above, patients posting on medical message
boards often use lay vocabulary to describe the symptoms they
are experiencing or the medicines they are taking. In order to ex-
tract useful information from these posts, a controlled vocabulary
of lay medical terms was constructed. Websites and databases con-
taining lists of dietary supplements, pharmaceuticals, and adverse
events were scraped for terms to populate the vocabulary. Since
most of these lists of terms had a regular structure (e.g., each term
was marked with an explicit HTML tag on a website or located in a
speciﬁc column of a database), we were able to collect the terms
using simple scripts, which were programmed, for example, to save
all terms that occur in a particular ﬁeld of a database or in a partic-
ular list on a webpage. Terms that were likely to result in false pos-
itives (e.g., event: boil, shake) were manually removed from the
vocabulary. The medical vocabulary consisted of the following:
 Dietary supplements: hand-compiled by one of the authors (JM),
who has expertise in complementary and alternative medicine:
507 terms
 Pharmaceuticals: Cerner Multum’s Drug Lexicon, (Denver, CO):
16,383 terms
 Events (terms that could either refer to an indication for a drug or
an adverse event caused by a drug): http://www.medicine
net.com/ and adverse events listed in the AERS database over
the period 2004 through the second quarter of 2009; not spe-
ciﬁc to breast cancer: 26,817 terms
tTable 1
Top 10 rules returned for tamoxifen ranked by count. Drug+/Event+ is the number of messages that contain the drug and event co-occurring within a 20 token window, Drug+/
Event is the number of messages containing only the drug and not the event, Drug/Event+ is the number of messages containing only the event and not the drug, and Drug/
Event is the number of messages mentioning neither the drug nor the event. p-Values in this list are very close to 0 or 1.
Event Drug/Event Drug/Event+ Drug+/Event Drug+/Event+ p-Value
Hot ﬂashes 1186,668 10,809 30,306 1949 0
Breast cancer 1135,252 62,225 30,914 1341 1
Menopause 1189,938 7539 31,236 1019 0
Pain 1114,656 82,821 31,547 708 1
Weight gain 1193,000 4477 31,751 504 4.47E143
Joint pain 1192,247 5230 31,780 475 3.12E104
Uterine cancer 1196,619 858 31,881 374 6.03E276
Fatigue 1182,660 14,817 31,973 282 1
Night sweat 1195,587 1890 31,981 274 1.40E100
Depression 1191,644 5833 32,001 254 1.53E12
Weight loss 1193,207 4270 32,055 200 9.69E13
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Vocabulary (CHV) provided by the Consumer Health Vocabulary
Initiative,1 in order to produce a vocabulary closer to the lay vocab-
ulary that would be used by patients on a discussion board. This also
provided us with a way of classifying several different terms as being
instances of a more general term (e.g., turmeric, tumeric [sic], and
curcumin are three different ways that a user may refer to
curcumin).
2.4. Step 4: Information extraction
After the anonymized corpus and controlled vocabularies were
generated, we generated frequency counts of each vocabulary term
in the corpus, in order to establish which terms are talked about
the most. This is similar to the Buzz count used in Glance et al.
[1]. We retrieved the single term counts by counting the number
of messages in which each term occurred. Each token was ﬁrst
stemmed using a Porter stemmer, an algorithm meant to remove
inﬂection from a word, from the Natural Language Toolkit (NLTK)
[28] before matching it to a term in the controlled vocabulary.
We also extracted association rules between pairs of terms. By
association rules we mean pairs of terms that co-occur within 20
tokens more frequently than would be expected if the terms were
distributed independently. These rules have no causal direction,
but simply suggest that there is a correlation between the presence
of one term and the presence of the other. In order to generate all
possible association rules between terms, all terms in the con-
trolled vocabulary occurring in the corpus were identiﬁed. Any
two terms co-occurring within a window of 20 tokens apart were
treated as a possible association rule; this window seemed to pro-
duce the best precision and recall of valid association rules over a
random sample of 500 messages.
Our approach of relying on co-occurrences of terms to generate
association rules has been used in several other systems
[2,5,14,18,29,30]. For each association rule (X, Y) output by the
query script, we constructed a 2 by 2 table of the occurrence of X
and Y and calculated a one-tailed Fisher’s exact p-value for that
rule, expressing the likelihood that these two terms co-occurred
independently by chance. All association rules with p-values great-
er than the Simes-corrected [31] 0.05 threshold were then deter-
mined to be non-signiﬁcant. We corrected the 0.05 threshold in
order to account for multiple testing bias, and in particular chose
Simes correction since it is not as strict as Bonferroni correction.
Even though Simes correction is not as conservative as Bonferroni
correction, the number of statistically signiﬁcant association rules
generated per drug was relatively low and could be analyzed by a
single person for possible signals (median of two statistically sig-1 http://www.consumerhealthvocab.org/.niﬁcant rules per drug, with a maximum of 95). However, rules
with very low counts were not ignored only because they were
infrequent; these low count pairs could potentially signal a rare,
but very real relationship between the two terms.3. Results
3.1. Validating the system
In order to validate our system, we selected four of the most
commonly used drugs to treat breast cancer: tamoxifen
(Nolvadex), anastrozole (Arimidex), letrozole (Femara), and exe-
mestane (Aromasin). Tamoxifen has long been the standard treat-
ment for hormonally-responsive breast cancer. Anastrozole,
letrozole, and exemestane are aromatase inhibitors, more recently
developed, that are also used to treat hormonally-responsive
breast cancer. We chose these four drugs because they have similar
indications and were frequently mentioned in the breast cancer
corpus. Table 1 shows the top 10 association rules by count iden-
tiﬁed by our system for tamoxifen.
For each of these four drugs, we compiled a documented list of
all adverse events (AEs) believed to occur from the drug. This list
was compiled from all of the AEs mentioned in tables and notes
contained in the drug label.
For each of the four drugs, we compiled a list of signiﬁcantly
associated events returned by our system. We then evaluated our
system’s performance by comparing our system list against the doc-
umented list for that particular drug using the precision and recall
metrics. In this context, precision was deﬁned as the proportion of
the events we found that occur in the documented list as AEs:
Precision ¼ # AEs in both the documented list and the system lis
# AEs in the system list
ð4Þ
Recall was deﬁned as the proportion of documented AEs occurring
in the system list:
Recall ¼ #AEs in both the documented list and the system list
#AEs in the documented list
ð5Þ
This method of evaluation is similar to that used to evaluate a phar-
macovigilance system over electronic health records by Wang et al.
[18] (see Table 2).
3.2. Identifying rare and novel events
In addition to evaluating our system for its ability to identify
many of the AEs listed on the drug label, we also investigated the
Table 2
Recall refers to the proportion of terms in the documented list that matched terms in
the system list, over the total number of terms in the documented list. Precision refers
to the proportion of terms in the system list that matched terms in the documented
list over the total number of terms in the system list. ‘N’ refers to the size of the
denominator for each value calculated.
Recall Precision
Value (%) N Value (%) N
Tamoxifen (Nolvadex) 42.4 66 79.1 62
Anastrozole (Arimidex) 36.8 76 75.0 55
Exemestane (Aromasin) 25.0 64 75.8 33
Letrozole (Femara) 35.6 59 78.0 41
All four drugs 35.1 265 77.0 191
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rare AEs or were not listed on the drug label at all. For example,
our system identiﬁed many AEs that were documented as rare
events for tamoxifen; these included ‘‘fatty liver’’, ‘‘uterine cancer’’,
‘‘stroke’’, and ‘‘pulmonary embolism’’. We referred back to the
messages where the terms occurred in order to determine the con-
text in which authors mentioned these events. A few anecdotes
from these messages are listed below. Note that the majority of
message board users referred to the aromatase inhibitors by their
brand names and these anecdotes reﬂect that.Block 2 Anecdotes of rare (as deﬁned by label) AEs occurring
with tamoxifen. Very few authors mentioned that they devel-
oped uterine cancer, and that they were simply scared of
developing it. For the other rare events, authors had men-
tioned that they actually experienced these AEs.I saw the liver specialist – was able to get in earlier
and he said my fatty liver is probably from taking
Tamoxifen.
I am still very scared, because Tamoxifen can cause
uterine cancer.
had a stroke recently, after finishing 5 yrs of Tamox-
ifen. This sealed my decision.
I was one of the few that developed a pulmonary
embolism while on Tamoxifen – lucky me.Although it is mentioned as a very rare AE on the label, ‘‘uterine
cancer’’ co-occurred 374 times with tamoxifen in our breast cancer
corpus. This does not necessarily suggest that it is a more common
AE than the label states, but simply that people frequently talk
about it. Most of these messages demonstrated anxiety about tak-
ing tamoxifen because of this side effect, rather than having actu-
ally developed uterine cancer. However, for other AEs, such as
‘‘pulmonary embolism’’ and ‘‘fatty liver’’, authors mentioned that
they had actually developed the conditions.
There were a few AEs that were reported with one of these four
drugs that were not listed on the drug label. Many of these were
false positives (i.e., AE and drug mentions were unrelated in the
posts, determined by human). However, there were a few signiﬁ-
cantly associated events (with p-value less than Simes-corrected
.05) that message board authors claimed to have actually occurred.
The following undocumented AEs were found to be based on in-
stances where message board authors claimed to have actually
experienced the AE.
 Tamoxifen: weight gain.
 Anastrozole: chapped lips, dry eye, lupus, conjunctivitis,
ﬁbromyalgia. Exemestane: dry eye, high cholesterol, vaginal dryness.
 Letrozole: mood swings, vaginal discharge.
Not all of these AEs may be truly caused by the drug, but, at the
very least, they may give practitioners a better idea of common
perceptions that patients hold about these drugs. A few examples
of posts where authors mentioned experiencing these AEs are
listed below in Block 3.Block 3 Sample anecdotes of undocumented AEs that message
board authors claimed to have experienced from tamoxifen,
anastrozole, exemestane, and letrozole.The only SEs i had on Tamoxifen were weight gain and
hot flashes/night sweats.
Has anybody been suffering from chapped, cracked
lips, especially at the corners of your mouth, since
being on Arimidex? I had this problem many years
ago but always could fix it by taking vitamin B com-
plex. The vitamin B complex isn’t helping any more
and I am wondering if Arimidex is causing this.
My eye doctor says my dry eyes are probably from age
— but he thinks Arimidex made them worse and sent a
letter to my DR. saying so.
2/07 Moved to Aromasin & Zometa because of Arimi-
dex triggering RA & Lupus
I’ve also had conjunctivitis 4 times. My onc said this
wasn’t a SE of arimidex but I know it is!
I’m now on arimidex. I am doing fine with BC but have
developed ﬁbromyalgia.
After about 1.5 years on Aromasin, my cholesterol
which is normally 186 was at 254. Something I have
not noticed anyone talking about is high cholesterol.
oh, should add. . .rather significant impact. . .of aroma-
sin – was vaginal dryness.
I am on aromasin and have developed dry eyes. does
anyone else have this problem?
slammed back with flushings, terrible night sweats,
bad mood swings, now have bad joint pain(mostly in
my ankle and right hand/thumb). oh ugh with the
femara!
Is there a side effect, that is B9, from Femara that
causes vaginal discharge? I just got home from a
cruise to AK and upon wake up this a.m. [sic] I had a
discharge. Not real bloody but kind of like the very last
day of a light period.4. Discussion
4.1. Contributions to low recall
Our system results in relatively low recall of drug AEs docu-
mented on the label, which seems particularly striking for more
common side effects, given that these AEs are very common and
one would expect authors to mention these symptoms frequently
in their posts. However, many of these common AEs are mentioned
very frequently throughout the entire corpus. One example is fati-
gue, a known AE of anastrozole, but also a potential effect of cancer
itself. The terms ‘‘fatigue’’ and ‘‘arimidex’’ co-occurred 210 times
within the breast cancer corpus. However, each of these terms oc-
curred in 15,099 and 17,124 messages, respectively, yielding a
non-signiﬁcant p-value. In order for the association rule ‘‘arimi-
dex-fatigue’’ to be signiﬁcant, these two terms would have had
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Our system seems better suited to ﬁnding rare AEs that are related
to a speciﬁc drug, such as ‘‘uterine cancer’’ for ‘‘tamoxifen’’. How-
ever, identifying new adverse events is probably a more appropri-
ate goal than measuring the frequency of known side effects.
It is also important to note that multiple event terms returned
by our system may match just a single AE in the documented AE
list. For example, if the documented AE list contained ‘‘pain in
extremity’’, then the terms ‘‘ﬁnger pain’’ and ‘‘toe pain’’ in the
system’s returned list would be considered members of the docu-
mented AE list. This also contributes to our system’s low recall.
The low recall against the documented list is due mostly to the
fact that the documented list is long. Some of the terms in this list
are pervasive within posts (e.g., fatigue, nausea, pain), and do not
co-occur frequently enough with the speciﬁc drug to suggest a sig-
niﬁcant association rule. However, other AEs in the documented
list are never mentioned by authors at all. Some examples of terms
that are absent from our breast cancer corpus but are documented
AEs for one or more of the four drugs we investigated are ‘‘in-
creased bilirubin’’, ‘‘increased creatinine’’, ‘‘thrombocytopenia’’,
‘‘increased alkaline phosphate’’, and ‘‘Stevens–Johnson syndrome’’.
Many of these are laboratory abnormalities that might not be no-
ticed or known by patients.
4.2. Undocumented events returned by system
Our system exhibited relatively high precision in the AEs that it
returned. However, on average, 23% of the drug-event rules
identiﬁed by our system were undocumented on the label. Some
of these undocumented AEs appeared to be unrelated to the drug.
These events tended to co-occur with the drug very infrequently
(generally less than 10 times), and occur very infrequently
throughout the corpus. Because the number of co-occurrences be-
tween the drug and event was so small, it was simple for us to refer
directly to the messages where these terms co-occurred and deter-
mine whether the author reported the event as being an AE of the
drug.
It is possible that some of the AEs returned could have been
inﬂuenced by ‘‘spam’’ posts in our corpus. However, we consider
this unlikely. Out of a random sample of 200 messages from the
breast cancer corpus, only one message (0.5%) could have been
construed as ‘‘spam’’. This message was a request for donations
to a group dedicated to providing ﬁnancial assistance to economi-
cally disadvantaged women with breast cancer. We believe that
the low level of spam in this corpus is due to message board users
monitoring the content of their respective boards and removing
messages that are posted by spammers. Thus, it is unlikely that
these undocumented drug AEs were due to spam messages.
Some pairs that our system identiﬁed were considered to be
false positives since they were not speciﬁcally documented as,
but were similar to, AEs on the drug label. ‘‘arimidex-gout’’ was
one of these pairs. Although gout is not a documented AE of anas-
trozole, it is a case of acute arthritis. The messages that mentioned
this event noted remedies for gout that may be effective in treating
aromatase inhibitor-induced arthritis. ‘‘Menopause’’ is an event
that was returned by all four drugs. Authors used the term ‘‘men-
opause’’ to describe the AEs that they were experiencing as meno-
pausal, particularly hot ﬂashes; they did not speciﬁcally claim that
a particular drug had induced menopause.
Our system does not determine the kind of relationship (indica-
tion or side effect) between the drug and event for each association
rule. Rather, it suggests only that the drug and event terms are cor-
related. For example, the events ‘‘bone density decreased’’, ‘‘bone
loss’’, and ‘‘osteoporosis’’ were all signiﬁcantly associated with
tamoxifen. However, tamoxifen is known to increase bone density
[32]. Referring back to the original messages where these eventterms and ‘‘tamoxifen’’ co-occurred revealed that post authors
were glad that tamoxifen prevented or remedied these events.
Some terms were actually contraindications for the drug, such as
‘‘Factor V Leiden mutation’’ (associated with an increased risk of
blood clots) for tamoxifen. Even though these terms were related
to the drug, they are not caused by the drugs and were thus treated
as false positives.
The remainder of the undocumented events consisted of mes-
sages where the author claimed to have experienced the AE in re-
sponse to the drug. Block 3 contains several examples of these
undocumented AEs. Some of these AEs may be common knowledge
in the medical community even though they are not listed on the
label. For example, it is known that tamoxifen tends to make it
more difﬁcult for patients to lose weight [33] even though neither
‘‘weight gain’’ nor ‘‘difﬁculty to lose weight’’ is mentioned as an AE
on the tamoxifen label. Other AEs mentioned in the corpus may not
be commonly accepted as an AE of that particular drug. Controlled
studies would be needed to verify that these undocumented AEs
actually occur from a particular drug. However, these anecdotes
may serve as signals that could be rigorously veriﬁed in controlled
studies.
4.3. Further work
We understand that medical message board corpora are very
different from clinical trial data, health care data, and databases
of reported adverse events. Medical message boards provide a
community and support for their members. Post authors not only
communicate how they are feeling and any AEs they have experi-
enced, but also AEs that they are worried about or that a friend
may have claimed to experience. However, given that we have
shown that our system is able to reliably extract known AEs for
several drugs, it may have potential utility for identifying undocu-
mented AEs for dietary supplements that breast cancer patients
use as well.
Extending the system to determine the relation between the
drug and event, for example, indication or AE, would be useful
for other drugs as well as nutritional supplements and herbal prep-
arations. We will also improve our system to extract other types of
information from medical message boards. Currently our system is
able to identify documented AEs of drugs with high precision by
the frequency that they co-occur. However, the current system
cannot determine what type of speech act the author used for each
speciﬁc case where they co-occurred. For example, the author
could be claiming that they actually experienced the AE, claiming
that their friend experienced the AE, wondering if a drug causes
that particular AE, or are just worried about a speciﬁc AE. Reﬁning
this system to identify these speech acts would enable our system
to be used as an alternative to focus groups. Another possible route
of exploration would be to extend our system to identify instances
of drug non-adherence, and identify the AEs that led to this
decision.
It would be interesting to know how people generally feel about
a particular drug, based on their posts on message boards. Do they
like a drug? Do they hate it? Why? Extending our system to per-
form a sentiment analysis on the breast cancer corpus would allow
researchers and medical practitioners to get a sense of what people
think about certain drugs.
We also intend to apply our system to medical message board
corpora for conditions other than breast cancer, in order to evalu-
ate its ability to generalize to other conditions. Currently we have
compiled corpora of obesity, diabetes, and arthritis message board
posts. These are ideal candidates for our method since they contain
a large number of messages because they are all chronic conditions
with a high prevalence. We expect similar results to those
generated from the breast cancer corpus. In addition, we will
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how well it identiﬁes relevant instances of drug and event
mentions.5. Conclusion
We have designed a system to identify signals of potential ad-
verse events that overcomes many of the difﬁculties associated
with medical message boards and is able to extract useful infor-
mation from them. Our system is able to generate a corpus of
medical message board text by downloading the message pages,
extracting the relevant ﬁelds from the pages, and programmati-
cally removing identifying information from the documents.
These de-identiﬁed documents are then searched for terms occur-
ring in the controlled vocabulary in order to extract association
rules that may signify meaningful relationships between these
terms.
We demonstrated the efﬁcacy of this system by extracting the
signiﬁcant drug-event association rules for four hormonal breast
cancer treatment drugs from a corpus of breast cancer message
board posts and compared this list to a list of all AEs that were doc-
umented on each drug label. Although our system’s recall over
these documented AE lists was relatively low (average of 35.1%),
the precision was relatively high (average of 77.0%), suggesting
that the terms in the signiﬁcant association rules returned are
not only correlated, but represent a real semantic relationship as
well.
In addition, we veriﬁed that some of the undocumented AEs
considered signiﬁcant by our system signaled an AE that message
board authors claimed to have experienced from the drug.
Whether or not the AE was actually caused by the drug is un-
known. However, it may signal a true AE from that drug, and
may be worth further investigation. Even if the AE is not caused
by the drug, it is useful to know what symptoms patients believe
(correctly or not) are being caused by the drug.
In future work, we plan to extend the system to identify the
speech act that was used for each drug-side effect mention and
to use this system to identify undocumented adverse effects from
dietary supplements.Authors’ contributions
J.H.H., J.M., L.U., S. Hennessy, and S. Hill conceptualized the re-
search. J.H.H., L.U., and S. Hill designed the system methodology.
J.M. reviewed the drug and supplement vocabularies. S. Hennessy,
J.M., and C.L. interpreted the drug-symptom ﬁndings. A.B. con-
structed the message board corpus and implemented the system.
A.C. contributed to the validation of the system. A.B. and J.H.H.
wrote the manuscript. All authors contributed to revision and ap-
proved this manuscript.Acknowledgments
This project is supported by the National Library of Medicine
(RC1LM010342). Access to the Lexicon database was supported
by the National Center for Research Resources (5Kl2RR024132).
We thank Cristin Freeman, MPH for providing access to the Lexicon
database and for sharing her expertise throughout the project. The
content is solely the responsibility of the authors and does not nec-
essarily represent the ofﬁcial views of the National Library of Med-
icine or the National Institutes of Health. This study was approved
by the Institutional Review Board at the University of
Pennsylvania.References
[1] Glance N, Hurst M, Nigam K, Siegler M, Stickton R, Tomokiyo T. Deriving
marketing intelligence from online discussion. In: Proceedings of the eleventh
ACM SIGKDD international Conference on Knowledge Discovery in Data
mining; 2005. p. 419–28.
[2] Feldman R, Fresco M, Goldenberg J, Netzer O, Ungar L. Extracting product
comparisons from discussion boards. In: Proceedings of the 2007 seventh IEEE
international conference on data mining; 2007. p. 469–74.
[3] Chklovski T. Deriving quantitative overviews of free text assessments on the
web. In: IUI ‘06: Proceedings of the 11th international conference on
intelligent user interfaces; 2006. p. 155–62.
[4] Dave K, Lawrence S, Pennock DM. Mining the peanut gallery: opinion
extraction and semantic classiﬁcation of product reviews. In: Proceedings of
the 12th international conference on world wide web; 2003. p. 519–28.
[5] Morinaga S, Yamanishi K, Fukushima T. Mining product reputations on the
web. KDD ‘02: In: Proceedings of the eighth ACM SIGKDD international
conference on Knowledge; 2002. p. 341–9.
[6] Mishne G. Using blog properties to improve retrieval. In: Proceedings of the
international conference on weblogs and social media (ICWSM); 2007.
[7] Gruhl D, Nagarajan M, Pieper J, Robson C. Context and domain knowledge
enhanced entity spotting in informal text. 8th International semantic web
conference (ISWC’09). In: Proceedings of the 8th international semantic web
conference (ISWC’09); 2009. p. 260–76.
[8] Hayes C, Avesani P, Bojars U. An analysis of bloggers, topics, and tags for a blog
recommender system. In: From web to social web: discovering and deploying
user and content proﬁles. Springer-Verlag; 2007. p. 1–20.
[9] Cousineau TM, Rancourt D, Green TC. Web chatter before and after the
Women’s Health Initiative results: a content analysis of on-line menopause
message boards. J Health Commun 2006;11(2):133–47.
[10] Donelle L, Hoffman-Goetz L. Health literacy and online health discussions of
North American Black women. Women Health 2008;47(4):71–90.
[11] Gooden RJ, Wineﬁeld HR. Breast and prostate cancer online discussion boards:
a thematic analysis of gender differences and similarities. J Health Psychol
2007;12(1):103–14.
[12] Meric F, Bernstam EV, Mirza NQ, Hunt KK, Ames FC, Ross MI, et al. Breast
cancer on the world wide web: cross sectional survey of quality of information
and popularity of websites. BMJ 2002;324(7337):577–81.
[13] Schultz PN, Stava C, Beck ML, Vassilopoulou-Sellin R. Internet message board
use by patients with cancer and their families. Clin J Oncol Nurs
2003;7(6):663–7.
[14] Malouf R, Davidson B, Sherman A. Mining web texts for brand associations. In:
Proceedings of the AAAI – 2006 spring symposium on computational
approaches to analyzing weblogs; 2006. p. 125–6.
[15] Almenoff JS, LaCroix KK, Yuen NA, Fram D, DuMouchel W. Comparative
performance of two quantitative safety signalling methods: implications for
use in a pharmacovigilance department. Drug Saf 2006;29(10):875–87.
[16] DuMouchel W, Pregibon D. Empirical bayes screening for multi-item
associations. In: Proceedings of the seventh ACM SIGKDD international
conference on knowledge discovery and data mining; 2001. p. 67–76.
[17] Wilson A, Thabane L, Holbrook A. Application of data mining techniques in
pharamcovigilance. Brit J Clin Pharmacol 2004;57(2):127–34.
[18] Wang X, Hripcsak G, Markatou M, Friedman C. Active computerized
pharmacovigilance using natural language processing, statistics, and
electronic health records: a feasibility study. J Am Med Inform Assoc
2005;16(3):328–37.
[19] Goldman JA, Chu WW, Parker DS, Goldman RM. Term domain distribution
analysis: a data mining tool for text databases. Meth Inform Med
2010;2010(2):96–101.
[20] Armstrong N, Powell J. Patient perspectives on health advice posted on Internet
discussion boards: a qualitative study. Health Expect 2009;12(3):313–20.
[21] Nahm ES, Resnick B, DeGrezia M, Brotemarkle R. Use of discussion boards in a
theory-based health web site for older adults. Nurs Res 2009;58(6):419–26.
[22] Copelton DA, Valle G. You don’t need a prescription to go gluten-free’’: the
scientiﬁc self-diagnosis of celiac disease. Social Sci Med 2009;69(4):623–31.
[23] Habermeyer E, Habermeyer V, Jahn K, Domes G, Nagel E, Herpertz SC. [An
internet based discussion board for persons with borderline personality
disorders moderated health care professionals] [German]. Psychiat Praxis
2009;36(1):23–9.
[24] Shigaki CL, Smarr KL, Yang G, Donovan-Hanson K, Siva C, Johnson RA, et al.
Social interactions in an online self-management program for rheumatoid
arthritis. Chronic Ill 2008;4(4):239–46.
[25] Finkel JR, Grenager T, Manning C. Incorporating non-local information into
information extraction systems by Gibbs sampling. ACL 2005. In: Proceedings
of the 43rd annual meeting of the association for computational linguistics;
2005. p. 363–70.
[26] Benton A, Hill S, Ungar L, Chung A, Leonard C, Freeman C, et al. A system for de-
identifying medical message board text. In: International conference on
machine learning and applications; 2010.
[27] Lafferty J, McCallum A, Pereira F. Conditional random ﬁelds: probabilistic
models for segmenting and labeling sequence data. In: Proceedings of the
eighteenth international conference on machine learning; 2001. p. 282–89.
[28] Bird S. NLTK: the natural language toolkit. Annual meeting of the ACL. In:
Proceedings of the COLING/ACL on interactive presentation sessions; 2004. p.
69–72.
996 A. Benton et al. / Journal of Biomedical Informatics 44 (2011) 989–996[29] Friedman C. Discovering novel adverse drug events using natural language
processing and mining of the electronic health record. In: Proceedings of the
12th conference on artiﬁcial intelligence in medicine: artiﬁcial intelligence in
medicine; 2009. p. 1–5.
[30] Eysenbach G. Infodemiology and infoveillance: framework for an emerging set
of public health methods to analyze search, communication and publication
behavior on the internet. J Med Int Res 2009;11(1).[31] Simes RJ. An improved Bonferroni procedure for multiple tests of signiﬁcance.
Biometrika 1986;73(3):751–4.
[32] Resch A, Biber E, Seifert M, Resch H. Evidence that tamoxifen preserves bone
density in late postmenopausal women with breast cancer. Acta Oncol
1998;37(7-8):661–4.
[33] Hoskin PJ, Ashley S, Yarnold JR. Weight gain after primary surgery for breast
cancer - effect of tamoxifen. Breast Cancer Res Treat 1992;22(2):129–32.
